AI and real-world evidence: The next frontier in clinical research
In the rapidly evolving world of clinical research, few developments hold as much promise—or provoke as much debate—as the…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Research
WSAI & Ohio State University researchers develop new AI framework to fast track drugs discovery
Researchers from IIT Madras’ Wadhwani School of Data Science and Artificial Intelligence (WSAI) and The Ohio State University,…
IIT Kanpur researchers develop novel sensor to monitor GPCRs in live cells
Researchers at the Indian Institute of Technology Kanpur (IIT Kanpur) have developed a novel antibody-based biosensor that can…
Cholrem study shows cyclodextrin-based therapy Cavadex reverses atherosclerotic cardiovascular…
Peer-reviewed research in Cardiology Research and Cardiovascular Medicine reports regression of arterial plaque and symptom relief…
DKMS opens applications for 2026 John Hansen Research Grant in stem cell transplantation and cell…
Up to four young scientists will receive €240,000 each over three years for research on haematopoietic stem cell transplantation…
Lilly’s Mounjaro (tirzepatide) demonstrated cardiovascular protection in a head-to-head trial
Mounjaro met the primary objective of non-inferiority vs. Trulicity with an 8 per cent lower rate of MACE-3 events, while…
Early Alzheimer’s patients continue to benefit from 4 yrs of LEQEMBI(R) (lecanemab-irmb)…
Data showed LEQEMBI slowed clinical decline by 1.75 points on CDR-SB at four years compared to the natural history of Alzheimer’s…
Biomarker identification to address unmet needs of idiopathic pulmonary fibrosis treatment:…
Promising biomarkers may include proteins such as serum amyloid A3 (SAA3)
India overtakes Iran in clinical trial initiations outside North America and Europe in Q2 2025
GlobalData’s latest report reveals that Iran’s clinical trials have been affected, with 348 trials initiated in Q2, compared to…
Baxdrostat met primary, secondary endpoints in BaxHTN Phase III trial in patients with…
Baxdrostat is a potential first-in-class, highly selective aldosterone synthase inhibitor that targets the hormone driving…
BD announces first pharma-sponsored clinical trial using BD Libertas wearable injector technology…
The BD Libertas Wearable Injector is a prefilled, patient ready-to-use drug delivery system designed to enable delivery of complex…
Sun Pharma’s phase 3 clinical studies evaluating ILUMYA in active psoriatic arthritis met their…
Treatment with tildrakizumab 100 mg (ILUMYA) resulted in greater improvements in PsA signs and symptoms at Week 24 compared to…
Auriga Research, SFRI sign MoU to build AI-integrated, globally compliant healthcare ecosystem
The partnership outlines a joint framework to support clinical trials, regulatory pathways, digital health innovation, and…
Asahi Kasei Pharma starts Phase III study of CIPN prevention therapy
Previous Phase I and II studies suggest efficacy and patient tolerability of ART-123 for CIPN by suppressing the activation of…
Role of nitric oxide in controlling genetic regulators to maintain cellular health
Prof Syamantak Majumder, Prof Sandeep Sundriyal, and Prof Shibasish Chowdhury, researchers at BITS Pilani, reveal how nitric oxide…
IGI reports phase 1 results of ISB 2001 trispecific antibody in relapsed or refractory multiple…
TRIgnite-1 study shows 79 per cent response rate and no dose-limiting toxicities in early-stage trial of BCMA × CD38 × CD3…
Sibeprenlimab’s priority review highlights potential to differentiate in IgAN space
Interim results showed that sibeprenlimab demonstrated a statistically significant and clinically meaningful reduction in 24-hour…
Vgenomics, Dr. Shroff Charity Eye Hospital partner to validate biomarker for early Keratoconus…
Novel tear-based biomarker aims at earlier intervention and improved patient outcomes in Keratoconus
Lupin announces presentation of phase 1 data on LNP7457 (PRMT5 inhibitor) at the ASCO – Annual…
Current data from Lupin indicates that LNP7457 is unique within its field and appears to be safe and well-tolerated as a…
Three factors to make a next-gen eCOA platform work
Melissa Mooney, Director, eCOA Solutions Engineering, IQVIA, emphasises that as timelines tighten, regulatory scrutiny…